In the open label (OL) study, after 6-months of daily nomlabofusp administration, 100% of participants (n = 10) achieved skin FXN levels similar ...

As fall outdoor activities increase, Arkansas residents are being warned about alpha-gal syndrome, a tick-borne illness that ...

How many shots are needed? Can I give it even if it’s beyond the age indication? My patient is immunocompromised—when do I ...

To answer these questions, registered dietitian nutritionist Carrie Dennett spoke with Georgia-based dietitian Sherry Coleman ...

Mr. Lewis introduced a new caveat into our discussion of the management of his pre-diabetes. “Well, doc, I’m struggling a bit with my low-carb diet lately. I contracted that alpha-gal ...

The University of Missouri Extension wants to spread awareness of alpha-gal syndrome. The MU Extension held a free workshop ...

U.S. net product revenue for the three and nine months ended September 30, 2025 was $40.7 million and $115.8 million, respectively, compared to $31.1 million and $84.2 million, for the comparable ...

Fire ants are a major biosecurity threat that can decimate crops, kill livestock and cause potentially deadly allergic ...

An invasive ant species native to East Asia has spread to every corner of North Carolina, and it can cause health and ...

Get key insights from Aquestive Therapeutics Q3 2025 earnings: Anaphylm launch prep, strong financing, FDA outlook, and market disruption.

Clinicians prescribing GLP-1 agents should ask about sexual function and consider medication review if new anorgasmia appears.

The FDA has accepted for Priority Review the sBLA for pegvaliase-pqpz in adolescents aged 12 to 17 years with phenylketonuria.